TOcilizumab and Covid-19 : Risk of Severe INfection
Clinical trial NCT05017441 · UNKNOWN
Trial details
- NCT number
- NCT05017441
- Sponsor
- Fondation Hôpital Saint-Joseph
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-08-16
- Primary completion
- 2023-12-31
- Enrollment
- 1200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.